Etonogestrel Patent Expiration

Etonogestrel is Used for contraception. It was first introduced by Organon Usa Llc in its drug Implanon on Jul 17, 2006. Another drug containing Etonogestrel is Nexplanon.


Etonogestrel Patents

Given below is the list of patents protecting Etonogestrel, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Implanon US9757552 Applicator for inserting an implant Jul 28, 2030 Organon
Nexplanon US9757552 Applicator for inserting an implant Jul 28, 2030 Organon
Nexplanon US8722037 X-ray visible drug delivery device Sep 28, 2027 Organon
Nexplanon US10821277 Kit for and method of assembling an applicator for inserting an implant May 31, 2027 Organon
Nexplanon US8888745 Applicator for inserting an implant Aug 28, 2026 Organon



Etonogestrel's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List